Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1 Registration statement (foreign)
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.2 EX-4.2
- 4.4 EX-4.4
- 5.1 EX-5.1
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
Associated filings
- 22 Jun 20 424B4 Prospectus supplement with pricing info
- 19 Jun 20 EFFECT Notice of effectiveness
- 18 Jun 20 FWP Free writing prospectus
- 18 Jun 20 F-1/A Registration statement (foreign) (amended)
- 15 Jun 20 F-1/A Registration statement (foreign) (amended)
- 4 Jun 20 F-1/A Registration statement (foreign) (amended)
-
21 Nov 19 F-1 Registration statement (foreign)
GTH similar filings
Filing view
External links
Exhibit 99.4
November 20, 2019
Genetron Holdings Limited(the“Company”)
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District
Beijing 102206, People’s Republic of China
Ladies and Gentlemen:
Pursuant to Rule 438 under the Securities Act of 1933, as amended, I hereby consent to the reference of my name as a director of the Company, effective immediately upon the effectiveness of the Company’s registration statement on Form F-1 initially filed by the Company on November [●], 2019 with the U.S. Securities and Exchange Commission.
Sincerely yours,
/s/ Webster K. Cavenee |
Name: Webster K. Cavenee |